An examination of nearly 200 medication adherence trials found that it is actually difficult to determine whether or not the approaches truly worked.
An examination of nearly 200 medication adherence trials found that it is actually difficult to determine whether or not the approaches truly worked.
A review published in the Cochrane Library examining data from some of the best trials testing approaches to increase medication adherence and patient health determined most trials had design flaws.
The trials studied a range of medical conditions and numerous different interventions for increasing medication adherence. Typically, only half of patients prescribed medications actually take them as prescribed.
“Across the body of evidence, effects were inconsistent from study to study, and only a minority of lowest risk of bias [randomized control tests] improved both adherence and clinical outcomes,” the authors determined. “Current methods of improving medication adherence for chronic health problems are mostly complex and not very effective, so that the full benefits of treatment cannot be realized.”
Just 17 of the total 182 trials analyzed were of high quality. These 17 trials combined several approaches, such as support from family members or pharmacists, education, and counseling. Just 5 of the 17 improved health outcomes and adherence.
“This review addresses one of the biggest challenges in healthcare, it’s a real surprise that the vast amount of research that has been done has not moved us further forward in our understanding of how to address this problem,” David Tovey, MD, editor-in-chief of the Cochrane Library, said in a statement. “With the costs of healthcare across the world increasing, we’ve never needed evidence to answer this question more than we do now.”
Among the 5 trials that improved health outcomes, there were no common interventions apparent. According to the authors, even the most effective interventions did make large improvements in outcomes or adherence.
A database of the relevant trials is now available to other researchers in the field to encourage collaboration and in-depth analyses.
"By making our comprehensive database available for sharing we hope to contribute to the design of better trials and interventions for medication adherence," lead researcher Robby Nieuwlaat of the Department of Clinical Epidemiology and Biostatistics at McMaster University, in Hamilton, Canada, said in a statement. "We need to avoid repeating the painful lessons of adherence research to date and begin with interventions that have shown some promise, or at least have not produced repeatedly negative results."
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Age Alone Is No Barrier to Allo-HCT for AML, Data Indicate
April 17th 2024A new study is among the largest real-world analyses to date to assess trends over time and predictive factors for older patients with acute myeloid leukemia (AML) who received allogeneic hematopoietic cell transplantation (allo-HCT).
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More